80
Participants
Start Date
November 1, 2023
Primary Completion Date
July 31, 2027
Study Completion Date
July 31, 2027
ISB 2001
Participants will receive escalating doses of ISB 2001
ISB 2001
Participants will receive injection of ISB 2001 as determined in Part 1.
RECRUITING
Concord Hospital, Concord
RECRUITING
Peter MacCallum Cancer Center, Melbourne
RECRUITING
St. Vincent's Hospital Melbourne, Fitzroy
RECRUITING
Pindara Private Hospital, Benowa
RECRUITING
Linear Clinical Research, Nedlands
RECRUITING
Montefiore Medical Center, The Bronx
RECRUITING
University of North Carolina, Chapel Hill
RECRUITING
Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
RECRUITING
University of Chicago Medical Center, Chicago
RECRUITING
Standford Cancer Institute, Palo Alto
RECRUITING
HCG Hospital, Bangalore
Lead Sponsor
Ichnos Sciences SA
INDUSTRY